logo
  Join        Login             Stock Quote

Philips showcases innovations in cardiology at European Society of Cardiology Congress 2013

Friday, August 30, 2013 9:00 AM


Philips showcases innovations in cardiology at European Society of Cardiology Congress 2013

-- New innovative solutions transform the way care is delivered and improve the quality of life for patients with cardiovascular diseases

-- Philips introduces EPIQ first of its kind ultrasound platform featuring 'anatomical intelligence' for whole-organ 3D visualization

AMSTERDAM, Aug. 30, 2013 /PRNewswire/ -- At the European Society of Cardiology Congress (ESC 2013) in Amsterdam, Royal Philips (NYSE: PHG, AEX: PHIA) will unveil the latest in a series of innovations aimed at helping cardiologists to improve patient outcomes and enhance clinical workflows. Developed in close collaboration with leading cardiologists, Philips' new solutions span the entire continuum of care -- from diagnosis to treatment and aftercare -- through the deployment of advanced diagnostics, patient-centric informatics and advanced interventional imaging to guide minimally invasive interventions. Closely following the introduction of important innovations such as Philips' AlluraClarity low-dose interventional X-ray imaging system and EchoNavigator navigation tool, the new introductions at ESC 2013 are further evidence of Philips' commitment to working with cardiologists to transform cardiology together.

(Logo:  http://photos.prnewswire.com/prnh/20110726/NY41282LOGO)

"Bringing meaningful innovation to healthcare across the continuum of care, in terms of clinical value, improved workflows, increased efficiency and cost containment, means working closely with clinical experts at the forefront of their field," said Deborah DiSanzo CEO Philips Healthcare. "That makes ESC 2013 an ideal place not only to show the world's cardiac care specialists what we have achieved so far, but also to engage with them in helping to create the future of cardiology."

Philips' new EPIQ ultrasound platform, which is being unveiled at ESC 2013, is the latest example of the integrated solutions that Philips is developing. For the first time, Anatomical Intelligence --  a rich data base of anatomic computer models and adaptive system technology -- has been built into an ultrasound system, creating an "active" ultrasound device achieving exceptional clinical results in less time.

Built around user insights, EPIQ provides an integrated 3D ultrasound technique that helps clinicians to interpret and quantify anatomies of interest, plan procedures and perform minimally-invasive interventions. The technology has been designed to overcome many of the usability, reproducibility and readability challenges related to conventional ultrasound, and to bridge the workflow between diagnosis, therapy planning and treatment.

"Because of its cost-effectiveness and versatility, ultrasound is one of the fastest growing segments in medical imaging, but it is also a highly competitive market where you need to deliver real added value in order to set yourself apart from the competition," said Gene Saragnese, CEO Imaging Systems at Philips Healthcare. "EPIQ is a perfect example of what you can achieve when you combine the latest technological developments with real user insights to move an imaging technology into a completely new level of performance."

Leveraging Philips' most powerful ultrasound and 3D visualization technologies, EPIQ breaks the rules of conventional ultrasound to achieve new levels of clinical performance. New promising diagnostic and interventional options will now become broadly available, not only in cardiology, but also for a wide range of other fields such as radiology and gynecology. This highly innovative new ultrasound platform is the result of a multi-year development program that forms part of Philips' continuous investment in healthcare R&D, which totaled EUR 803 million in 2012 alone.

Next to EPIQ, Philips is showcasing several new products at ESC 2013 that demonstrate its 'Transforming Cardiology, Together' approach of engaging with cardiologists to identify user needs, addressing customers' top-of-mind, real-life issues and concerns. These new products include:

  • For the first time shown in Europe are both the Philips IntelliSpace ECG and ST80i Stress Testing System. With the introduction of the IntelliSpace ECG -- a multi-modality, multi-vendor and scalable ECG management system -- patient data can be accessed from other points-of-care applications for review, comparison and printing. Holter and Stress (e.g., ST80i) PDF reports as well as other modality reports can be verified, assigned, electronically signed, and easily exported to a customer's EMR. The Philips ST80i Stress Testing System features a wireless patient experience, bi-directional connectivity and advanced decision support tools that enhance data review, patient care and workflow efficiency.
  • Xcelera R4.1 -- the latest release of the Philips Xcelera multimodality cardiology solution provides patient-centric access to cardiology data and examinations for image management, analysis and reporting. With both 64-bit and 32-bit operating system compatibility, Xcelera helps institutions leverage IT investments across departments, guarantees business continuity and enhances data intensive processing. The update also includes a thin client version of the Cardiology Enterprise Viewer (Xcelera CEV R2.1), where access to images is as close as an internet connection, providing clinicians with the benefits of increased ease-ohif-use and lower implementation costs.

Visit Philips at ESC 2013 in Amsterdam, at booth A300 from August 31 till September 4 to see EPIQ and Philips' other innovative technology solutions. For more information, please go to www.philips.com/esc.

For further information, please contact:

Rachel Bloom-Baglin
Philips Healthcare
Tel: +1 978 7609007
E-mail: rachel.bloom-baglin@philips.com

Steve Klink
Philips Corporate Communications
Tel.: +31 6 10888824
E-mail: steve.klink@philips.com

About Royal Philips Electronics:

Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 115,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.

 

  

(Source: PR Newswire )
(Source: Quotemedia)

Advertisement
Advertisement



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.